SENZA — SenzaGen AB Income Statement
0.000.00%
Last trade - 00:00
- SEK225.44m
- SEK209.48m
- SEK49.87m
- 33
- 11
- 41
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.72 | 7.96 | 15.4 | 41.8 | 49.9 |
Cost of Revenue | |||||
Gross Profit | 3.5 | 5.58 | 9.45 | 27.3 | 34.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40.7 | 35.1 | 47 | 66.9 | 72.4 |
Operating Profit | -37.9 | -27.1 | -31.5 | -25.1 | -22.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -37.7 | -27.2 | -31.4 | -25 | -22 |
Provision for Income Taxes | |||||
Net Income After Taxes | -50.2 | -27.2 | -31.3 | -24.9 | -22.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -50.2 | -27.2 | -31.3 | -24.9 | -22.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -50.2 | -27.2 | -31.3 | -24.9 | -22.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.06 | -1.27 | -1.35 | -0.823 | -0.576 |
Dividends per Share |